NCT05428358

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery (MAGIPAC): A Randomized Clinical Trial.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: University of Aarhus · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.

Detailed description

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients. We will conduct a nationwide, prospective clinical trial to examine the incremental value of using MRI for identification of liver metastases in pancreatic cancer patients.

Conditions

• Pancreatic Cancer
• Pancreatic Neoplasm
• Liver Metastases

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Preoperative MRI	Preoperative MRI performed between outpatient visit at the surgical clinic and scheduled date of resection

Timeline

• Start date: 2022-08-30
• Primary completion: 2027-12-01
• Completion: 2028-12-01
• First posted: 2022-06-23
• Last updated: 2025-11-18

Locations

3 sites across 1 country: Denmark